Originally published in our sister publication, Pain Medicine News.
A joint pilot program between the FDA and the National Telecommunications and Information Administration (NTIA) looks to help reduce the availability of unapproved opioids illegally offered for sale online.
As part of the program, the FDA will notify participating internet registries—Neustar, Verisign and Public Interest Registry—when the agency sends a warning letter to a website operator that subsequently does